Skip to content

Dolby Laboratories

US · DLB #2013 by market cap Listed 1970
58.35 -0.11 -0.19%
Live - 5344 symbols - heartbeat 401s ago · 2026-10-08 04:26
Pre-market 58.40 +0.09%
After-hours 58.34 -0.02%
Market cap
5.47B
P/B
2.12
EPS
2.62
Reader sentiment Are you bullish or bearish on DLB?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Below fair value
69.20 fair value ≈ 86.51 103.83
  • Implied fair-value range of 69.20-103.83, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -32.6% below the average-multiple fair value of 86.51.

Valuation each multiple against its own 5-year range

P/B ratio 2.12 Cheap vs history 6th percentile
5-year average 2.94 · #22 of 43 in Specialty Business Services
P/E ratio 24.91 Cheap vs history 10th percentile
5-year average 33.02 · forward 19.29 · #15 of 27 in Specialty Business Services
P/S ratio 4.05 Cheap vs history 6th percentile
5-year average 5.66 · forward 3.76 · #33 of 46 in Specialty Business Services

Vs. peers Specialty Business Services

Company Market cap P/E (TTM) P/B Div yield
Dolby Laboratories (DLB) 5.47B 24.83 2.12 2.42%
Cintas (CTAS) 78.30B 38.89 15.04 0.95%
RELX PLC (RELX) 59.98B 20.98 36.68 2.56%
Thomson Reuters (TRI) 43.01B 26.25 3.87 2.55%
Copart (CPRT) 24.66B 17.17 2.71 0.00%
Global Payments (GPN) 21.46B -26.76 0.93 1.23%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value74.74 Economic moatNarrow UncertaintyLow

Trading 28.1% below Morningstar's fair value estimate.

Fair value

Dolby Laboratories Inc is assigned a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 21% discount to our quantitative fair value estimate of $74.74 per share, which is reinforced by this estimate's low uncertainty rating.

The firm's profitability increases our estimated valuation. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. For example, the firm's enterprise value to free cash flow ratio of 11.1 ranks in the bottom 20% compared with global peers. This can be a sign of operational efficiency and potential for the company to fund growth, pay dividends, or reduce debt without needing additional capital. We believe this is a sign that shares could be undervalued.

Conversely, the firm's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to market value ratio of 0.9, for example, lies in the bottom 30% globally. The market value of equity makes up a large fraction of enterprise value, indicating that shares have sharply risen, or that the company has a "lazy" balance sheet that is underleveraged. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has been a laggard relative to the broader universe over the past year. This underperformance makes the stock appear cheap, which portends a buying opportunity in light of other contributors to our model.

Economic moat

The company's narrow economic moat rating suggests it should be able to maintain robust profitability for a decade or longer before competition erodes its advantage. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.

By Quantitative Equity Report

Quote time 2026-10-08 04:26:38 · For reference only, not investment advice and not tailored to your situation.